Before answering your question, let’s first discuss some essential points:
What is dementia? As soon, somebody has “memory problems”, a diagnosis of “dementia” comes in mind. However, the definition of dementia is much more complex. Dementia is a clinical syndrome of cognitive decline that is sufficiently severe to interfere with social or occupational ...
What you are hearing about is probably based on two articles:
Interaction of cinnamaldehyde and epicatechin with tau: implications of beneficial effects in modulating Alzheimer's disease pathogenesis
Orally Administrated Cinnamon Extract Reduces β-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer's Disease Animal Models
They led to ...
Neurodegenerative diseases are diagnosed on the basis of clinical symptoms (memory impairment for Alzheimer Disease/ bradykinesia, tremor and rigor for Parkinson Disease) +/- neuropsychological tests.
The current role of neuroimaging in the diagnosis of neurogenerative diseases such as Parkinson Disease or Alzheimer Disease is mainly supportive, it can be ...
There are four cognitive symptom categories for Alzheimer's disease: aphasia, amnesia, apraxia, agnosia. These are broad categories that our brains handle somewhat separately. People frequently do sustain a brain injury to the left side of the head that damages his or her ability to process language and speech without affecting any other cognitive abilities. ...
You should read the article carefully. In the Introduction section they give some insight for their study:
The majority of AD cases are sporadic in nature. The small fraction of familial cases are caused primarily by mutations in three genes: amyloid precursor protein (APP), presenilin1 (PS1), and presenilin 2 (PS2).
They clearly specify what they are ...
Diagnosis of Alzheimer's Disease is something only a medical professional can do. However, the symptoms are often first observed by friends and family, and here is what the physician will look for:
Significant memory problems in immediate recall, short-term, or long-term memory.
Significant thinking deficits in at least one of four areas: expressing or ...
How about this list from the Alzheimer Society of Canada? It differentiates between modifiable and non-modifiable risk factors and goes on to explain how and why which risk factors are risk factors.
- Risk factors for both Alzheimer’s disease and cardiovascular diseases
- High Blood Pressure
- High ...
General rule of thumb: Reduce the amount of dirt and dust in the air you breathe.
This question does currently not specify if those profiles are just handled and assembled in a bedroom. That should be fine.
However, implicitly one can read that as asking for: if those profiles get drilled and sawed and machine polished, then a certain amount of dust and ...
An extension trial A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia is currently in progress but is not expected to complete until 9/2020.
Other investigational drugs have ceased development. A paper here suggests chitosan polysaccharides have in vitro activity as inhibitors.
We don't know how risky aluminum is. (Source.)
In Germany, the Federal Institute for Risk Assessment (BfR) wondered about kettles too.
They wrote an article named "FAQs about aluminium in food and products intended for consumers". I shall quote a bunch from that article; their final answer to your question is at the very end of my post.
What health ...
It is now widely accepted that Alzheimer's disease is a form of cerebral amyloidosis (in fact the most common form of amyloidosis).
The amyloidoses and prionoses are examples of protein misfloding diseases.
Amyloidosis: Abnormal proteins (amyloid fibrils) build up in tissues when they form incorrectly and are not completely broken down by protease enzymes. ...